The Venari Blog

In 2020, women-led start-ups received just 2.3% of VC funding, only 4.9% of all U.S. based VC Partners are women. On the occasion of the...

As Q4 begins and the world starts to recover from the effects of the pandemic, we are seeing hiring volumes skyrocket. To help guide...

Ben Brickell Director Life Sciences & Healthcare The Life Sciences & Healthcare recruitment market continues to evolve at lightning speed...

Healthcare organisations have had a lot to contend with, in the last 18 months. The Coronavirus pandemic and its lingering impacts have...

One of our clients in the Life Sciences sector has committed to achieving full gender equality in their leadership positions globally by...

Takashi Takenoshita was a London-based healthcare partner in a leading global strategic consulting firm. During his 19 years consulting...

Loren Busby is a venture partner to fund managers as well as a business advisor to portfolio companies. She has over two decades of...

For many companies, the pandemic has shifted the focus from traditional healthcare benefits to more inclusive and holistic wellbeing...

Are you thinking about taking a Board role at some point? Ben Brickell, our Director of Life Sciences, interviewed Bob Ward. Bob has...

We promised to continue last week’s discussion with Michael Easton to bring you some of his tips on revising an organisation’s mission...

The last 12 months have thrown the world upside down, and the corporate world is no different. Michael Easton, the former Global Head of...

Venari Partners was retained by the newly-appointed Chief Commercial Officer of a clinical-stage biotech company to build out the...

With the increased demand for the transportation of pharmaceutical products and medical supplies globally, our Life Sciences & Healthcare...

The UK Government has been under some criticism lately due to its alleged ‘relaxed’ approach to tackling the coronavirus outbreak....

With the recent announcement of the Covid-19 pandemic, all eyes are on the scientific research community to develop an effective vaccine...

Hamburg. The home of Montblanc, Nivea, Holsten Lager…and this year’s much awaited Bio-Europe conference! On a fresh and wintery 2 degree...

Cannabis may prove to be the miracle drug of the century. Cancer, chronic pain, anxiety, epilepsy, asthma, insomnia, autism, PTSD,...

A mid-sized European Biotech company retained Venari Partners to expand its Business Development team. The purpose of this project was to...

A well-funded Biotech incubator retained Venari Partners to identify CEO / COO profiles for their newly formed portfolio companies. The...

When Roche acquired Genentech and then Sanofi acquired Genzyme, the wheels were firmly set in motion for a new age of M&A strategy. Big...